| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Pathology Division [S. U., H. T., M. N., S. H.], Genetics Division [M. T., T. Su.], and Section of Study on Cancer Metastasis [J. Y.], National Cancer Center Research Institute, 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104, and Department of Surgery I, Oita Medical University, 1-1506, Idaigaoka, Hasama-Machi, Oita Gun, Oita 879-56, [S. U., T. Sa., M. K.], Japan
We examined 28 cases of surgically resected gastric cancer, excluding the diffuse type, for loss of heterozygosity (LOH) on 12 chromosomal arms using polymorphic DNA markers. LOH on chromosome 18q was detected in 61% (14 of 23) of the cases by the probes OLVIIA8, OLVIIE10, p15–65, SAM 1.1, and OS-4, and a putative common region showing LOH included the locus of the DCC tumor suppressor gene. LOH on chromosome 17p was also frequently found (8 of 19 or 42% of the cases) by the probes p10–3 and pHF12–1, and in 5 of these 6 cases the LOH on chromosome 17p was accompanied by LOH on chromosome 18q. On the other hand, the incidence of LOH was 30% or less using probes pHRnES, pHF12–65, p-c-mybE2.6, NJ3 3.2, pHF12–8, pHINS6.0, p9D11, hp2-
, pCMM6, and P1A5 on chromosomes 1q, 5, 6q, 7q, 9, 11p, 13q, 16q, 20, and 22q, respectively. LOH on chromosome 18q was frequent irrespective of the depth of tumor invasion, whereas the incidence of LOH on chromosome 17p was higher in the cases in which the tumor invaded beyond the muscularis propria than in those in which tumor invasion was limited to the submucosa and muscularis propria.
These results suggest that LOH on chromosome 18q occurs at an earlier stage than LOH on chromosome 17p and that the inactivation of tumor suppressor genes located on chromosome 17p and 18q (e.g., the p53 and DCC genes) is critically involved in the development of the majority of gastric cancers. While alteration of the p53 gene is observed in various human cancers, that of the DCC gene is considered to occur more selectively in gastrointestinal cancers.
1 Supported in part by a Grant-in-Aid from the Ministry of Health and Welfare of Japan for the Comprehensive 10-Year Strategy for Cancer Control.
2 S. U. is a recipient of a Research Resident Fellowship from the Foundation for the Promotion of Cancer Research.
3 To whom reprint requests should be addressed.
Received 10/25/91. Accepted 3/19/92.
This article has been cited by other articles:
![]() |
A Bamias, Z Yu, P. Weinberger, S Markakis, D Kowalski, R. Camp, D. Rimm, M. Dimopoulos, and A Psyrri Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with {beta}-catenin levels and outcome in patients with epithelial ovarian cancer Ann. Onc., December 1, 2006; 17(12): 1797 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, J. Aurandt, C. Jurgensen, Y. Rao, and K.-L. Guan FAK and Src kinases are required for netrin-induced tyrosine phosphorylation of UNC5 J. Cell Sci., January 1, 2006; 119(1): 47 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mehlen and E. R. Fearon Role of the Dependence Receptor DCC in Colorectal Cancer Pathogenesis J. Clin. Oncol., August 15, 2004; 22(16): 3420 - 3428. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Suzuki, K. Egami, K. Sasajima, M. Ghazizadeh, H. Shimizu, H. Watanabe, H. Hasegawa, S. Iida, T. Matsuda, Y. Okihama, et al. Comparative Study between DNA Copy Number Aberrations Determined by Quantitative Microsatellite Analysis and Clinical Outcome in Patients with Stomach Cancer Clin. Cancer Res., May 1, 2004; 10(9): 3013 - 3019. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Aqeilan, T. Kuroki, Y. Pekarsky, O. Albagha, F. Trapasso, R. Baffa, K. Huebner, P. Edmonds, and C. M. Croce Loss of WWOX Expression in Gastric Carcinoma Clin. Cancer Res., May 1, 2004; 10(9): 3053 - 3058. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. H. Kim, H. S. Lee, H.-J. Lee, K. Hur, W. H. Kim, Y.-J. Bang, S.-J. Kim, K. U. Lee, K. J. Choe, and H.-K. Yang Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas Ann. Onc., April 1, 2004; 15(4): 574 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Moragoda, R. Jaszewski, P. Kulkarni, and A. P. N. Majumdar Age-associated loss of heterozygosity of tumor suppressor genes in the gastric mucosa of humans Am J Physiol Gastrointest Liver Physiol, June 1, 2002; 282(6): G932 - G936. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Hara, M Saegusa, T Mikami, and I Okayasu Loss of DCC expression in astrocytomas: relation to p53 abnormalities, cell kinetics, and survival J. Clin. Pathol., November 1, 2001; 54(11): 860 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Knuutila, Y. Aalto, K. Autio, A.-M. Bjorkqvist, W.'e. El-Rifai, S. Hemmer, T. Huhta, E. Kettunen, S. Kiuru-Kuhlefelt, M. L. Larramendy, et al. DNA Copy Number Losses in Human Neoplasms Am. J. Pathol., September 1, 1999; 155(3): 683 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Zullo, A Romiti, V Rinaldi, A Vecchione, S Tomao, F Aiuti, L Frati, and G Luzi Gastric pathology in patients with common variable immunodeficiency Gut, July 1, 1999; 45(1): 77 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Yustein, J. C. Harper, G. R. Petroni, O. W. Cummings, C. A. Moskaluk, and S. M. Powell Allelotype of Gastric Adenocarcinoma Cancer Res., April 1, 1999; 59(7): 1437 - 1441. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oya, T. Yao, and M. Tsuneyoshi Numerical Chromosomal Aberration in NodePositive Early Gastric Carcinomas: Analysis by Fluorescence in Situ Hybridization and Immunohistochemical Staining International Journal of Surgical Pathology, October 1, 1998; 6(4): 189 - 196. [Abstract] [PDF] |
||||
![]() |
D. Shibata, M. A. Reale, P. Lavin, M. Silverman, E. R. Fearon, G. Steele, J. M. Jessup, M. Loda, and I. C. Summerhayes The DCC Protein and Prognosis in Colorectal Cancer N. Engl. J. Med., December 5, 1996; 335(23): 1727 - 1732. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Hedrick, K R Cho, E R Fearon, T C Wu, K W Kinzler, and B Vogelstein The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes & Dev., May 15, 1994; 8(10): 1174 - 1183. [Abstract] [PDF] |
||||
![]() |
T Sugimura Multistep carcinogenesis: a 1992 perspective Science, October 23, 1992; 258(5082): 603 - 607. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |